CD
Chapin Davis’s GSK GSK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $379K | Sell |
9,877
-533
| -5% | -$20.5K | 0.1% | 162 |
|
|
2025
Q1 | $403K | Sell |
10,410
-4,088
| -28% | -$158K | 0.14% | 140 |
|
|
2024
Q4 | $593K | Hold |
14,498
| – | – | 0.19% | 115 |
|
|
2024
Q3 | $593K | Sell |
14,498
-93
| -0.6% | -$3.8K | 0.19% | 116 |
|
|
2024
Q2 | $562K | Buy |
14,591
+360
| +3% | +$13.9K | 0.19% | 119 |
|
|
2024
Q1 | $610K | Buy |
14,231
+300
| +2% | +$12.9K | 0.22% | 105 |
|
|
2023
Q4 | $516K | Hold |
13,931
| – | – | 0.22% | 115 |
|
|
2023
Q3 | $505K | Sell |
13,931
-2,610
| -16% | -$94.6K | 0.24% | 103 |
|
|
2023
Q2 | $590K | Sell |
16,541
-168
| -1% | -$5.99K | 0.28% | 96 |
|
|
2023
Q1 | $594K | Sell |
16,709
-330
| -2% | -$11.7K | 0.31% | 92 |
|
|
2022
Q4 | $599K | Buy |
+17,039
| New | +$599K | 0.35% | 84 |
|